Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2026-05-07 17:33:52 ET · period of report 2026-05-05 · accession 0001214659-26-005750 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 17:33 | 2026-05-05 | AQST | Barber Daniel | Pres, CEO | F - Tax | $4.18 | -335.9K | 668.8K | -33% | -$1.40M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-05 | F | D | 335,922 | $4.18 | 668,831 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. |